Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation.

Abstract

Recently, an inherited syndrome characterized by nonmalignant lymphoproliferation with autoimmune manifestations, caused by mutations of the Fas (CD95) receptor gene has been described. Because of disease severity, i.e. unremitting lymphoproliferation in a child with complete Fas deficiency, a haploidentical bone marrow transplantation (BMT) was performed despite the known resistance of Fas-deficient lpr mice to bone marrow transplantation. Marrow graft was rejected early; however, a second attempt using bone marrow from the mother led to engraftment and to control of lymphoproliferation and of autoimmune thrombocytopenia up to the last follow-up at 24 months after BMT. This single case shows that resistance to bone marrow engraftment caused by survival of Fas-deficient cells can be overcome.

• Authors: M Benkerrou, F Le Deist, J P de Villartay, S Caillat-Zucman, F Rieux-Laucat, N Jabado, M Cavazzana-Calvo, A Fischer
• Journal: European journal of immunology (Eur J Immunol) Vol. 27 Issue 8 Pg. 2043-7 (Aug 1997) ISSN: 0014-2980 [Print] Germany
• PMID: 9295043 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• fas Receptor

Topics

• Animals
• Autoimmune Diseases (genetics, immunology, therapy)
• Bone Marrow Transplantation (immunology)
• Female
• Graft Survival
• Haplotypes
• Humans
• Infant
• Lymphoproliferative Disorders (genetics, immunology, therapy)
• Mice
• Mice, Inbred MRL lpr
• Mutation
• Syndrome
• Time Factors
• fas Receptor (genetics, metabolism)